Logo image of ACNT

ASCENT INDUSTRIES CO (ACNT) Stock Fundamental Analysis

NASDAQ:ACNT - Nasdaq - US8715651076 - Common Stock - Currency: USD

12.98  +0.08 (+0.62%)

Fundamental Rating

3

ACNT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 152 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for ACNT as it has an excellent financial health rating, but there are worries on the profitability. ACNT has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ACNT had negative earnings in the past year.
ACNT had a positive operating cash flow in the past year.
In multiple years ACNT reported negative net income over the last 5 years.
Each year in the past 5 years ACNT had a positive operating cash flow.
ACNT Yearly Net Income VS EBIT VS OCF VS FCFACNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

1.2 Ratios

Looking at the Return On Assets, with a value of -9.23%, ACNT is doing worse than 67.76% of the companies in the same industry.
The Return On Equity of ACNT (-14.54%) is worse than 65.13% of its industry peers.
Industry RankSector Rank
ROA -9.23%
ROE -14.54%
ROIC N/A
ROA(3y)-5.78%
ROA(5y)-4.58%
ROE(3y)-7.62%
ROE(5y)-7.75%
ROIC(3y)N/A
ROIC(5y)N/A
ACNT Yearly ROA, ROE, ROICACNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

ACNT has a Gross Margin (12.43%) which is in line with its industry peers.
ACNT's Gross Margin has improved in the last couple of years.
ACNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.87%
GM growth 5Y4.26%
ACNT Yearly Profit, Operating, Gross MarginsACNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

7

2. Health

2.1 Basic Checks

ACNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACNT has less shares outstanding than it did 1 year ago.
ACNT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACNT has an improved debt to assets ratio.
ACNT Yearly Shares OutstandingACNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACNT Yearly Total Debt VS Total AssetsACNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.48 indicates that ACNT is not in any danger for bankruptcy at the moment.
ACNT's Altman-Z score of 3.48 is fine compared to the rest of the industry. ACNT outperforms 64.47% of its industry peers.
ACNT has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
ACNT's Debt to FCF ratio of 0.13 is amongst the best of the industry. ACNT outperforms 92.76% of its industry peers.
ACNT has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.01, ACNT is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Altman-Z 3.48
ROIC/WACCN/A
WACC10.26%
ACNT Yearly LT Debt VS Equity VS FCFACNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 3.73 indicates that ACNT has no problem at all paying its short term obligations.
ACNT's Current ratio of 3.73 is fine compared to the rest of the industry. ACNT outperforms 75.66% of its industry peers.
ACNT has a Quick Ratio of 1.89. This is a normal value and indicates that ACNT is financially healthy and should not expect problems in meeting its short term obligations.
ACNT has a Quick ratio (1.89) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 1.89
ACNT Yearly Current Assets VS Current LiabilitesACNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 85.91% over the past year.
ACNT shows a decrease in Revenue. In the last year, the revenue decreased by -7.93%.
Measured over the past years, ACNT shows a very negative growth in Revenue. The Revenue has been decreasing by -10.24% on average per year.
EPS 1Y (TTM)85.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.33%
Revenue 1Y (TTM)-7.93%
Revenue growth 3Y-19%
Revenue growth 5Y-10.24%
Sales Q2Q%-1.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y229.52%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACNT Yearly Revenue VS EstimatesACNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
ACNT Yearly EPS VS EstimatesACNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2023 2024 2025 0 1 -1 -2 -3 -4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACNT. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 15.91, which indicates a correct valuation of ACNT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACNT indicates a somewhat cheap valuation: ACNT is cheaper than 69.74% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ACNT to the average of the S&P500 Index (21.38), we can say ACNT is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.91
ACNT Price Earnings VS Forward Price EarningsACNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

ACNT's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, ACNT is valued cheaply inside the industry as 92.11% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.23
EV/EBITDA 39.04
ACNT Per share dataACNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ACNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ASCENT INDUSTRIES CO

NASDAQ:ACNT (4/25/2025, 8:00:00 PM)

12.98

+0.08 (+0.62%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)05-13 2025-05-13/amc
Inst Owners44.93%
Inst Owner ChangeN/A
Ins Owners13.68%
Ins Owner Change0.28%
Market Cap130.84M
Analysts85.71
Price TargetN/A
Short Float %0.23%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-139.68%
Min EPS beat(2)-212.04%
Max EPS beat(2)-67.32%
EPS beat(4)1
Avg EPS beat(4)-57.84%
Min EPS beat(4)-212.04%
Max EPS beat(4)91.09%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.55%
Min Revenue beat(2)-25.03%
Max Revenue beat(2)-14.07%
Revenue beat(4)1
Avg Revenue beat(4)-9.74%
Min Revenue beat(4)-25.03%
Max Revenue beat(4)8.66%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.91
P/S 0.74
P/FCF 10.23
P/OCF 8.91
P/B 1.4
P/tB 1.51
EV/EBITDA 39.04
EPS(TTM)-0.63
EYN/A
EPS(NY)0.82
Fwd EY6.29%
FCF(TTM)1.27
FCFY9.77%
OCF(TTM)1.46
OCFY11.22%
SpS17.65
BVpS9.28
TBVpS8.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.23%
ROE -14.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.43%
FCFM 7.19%
ROA(3y)-5.78%
ROA(5y)-4.58%
ROE(3y)-7.62%
ROE(5y)-7.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.87%
GM growth 5Y4.26%
F-Score8
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Debt/EBITDA 0.34
Cap/Depr 25.48%
Cap/Sales 1.06%
Interest Coverage N/A
Cash Conversion 495.65%
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 1.89
Altman-Z 3.48
F-Score8
WACC10.26%
ROIC/WACCN/A
Cap/Depr(3y)34.33%
Cap/Depr(5y)30.57%
Cap/Sales(3y)1.26%
Cap/Sales(5y)1.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.33%
EPS Next Y229.52%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.93%
Revenue growth 3Y-19%
Revenue growth 5Y-10.24%
Sales Q2Q%-1.32%
Revenue Next Year6.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y82.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year361.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-36.67%
FCF growth 3Y-10.03%
FCF growth 5Y-11.9%
OCF growth 1Y-36.39%
OCF growth 3Y-8.33%
OCF growth 5Y-12.51%